Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 2014
|
| In: |
OncoTarget
Year: 2014, Jahrgang: 5, Heft: 16, Pages: 6620-6632 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.2268 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.2268
|
| Verfasserangaben: | Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1527153185 | ||
| 003 | DE-627 | ||
| 005 | 20220812172641.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160304s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.2268 |2 doi | |
| 035 | |a (DE-627)1527153185 | ||
| 035 | |a (DE-576)457153180 | ||
| 035 | |a (DE-599)BSZ457153180 | ||
| 035 | |a (OCoLC)1340902093 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Aichler, Michaela |d 1977- |e VerfasserIn |0 (DE-588)136784135 |0 (DE-627)587249137 |0 (DE-576)287406601 |4 aut | |
| 245 | 1 | 0 | |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy |c Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch |
| 264 | 1 | |c August 2014 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.03.2016 | ||
| 700 | 1 | |a Ott, Katja |d 1971- |e VerfasserIn |0 (DE-588)118131257 |0 (DE-627)079261914 |0 (DE-576)291731244 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 5(2014), 16, Seite 6620-6632 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy |
| 773 | 1 | 8 | |g volume:5 |g year:2014 |g number:16 |g pages:6620-6632 |g extent:13 |a Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.2268 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160304 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 118131257 |a Ott, Katja |m 118131257:Ott, Katja |d 910000 |d 910200 |e 910000PO118131257 |e 910200PO118131257 |k 0/910000/ |k 1/910000/910200/ |p 6 | ||
| 999 | |a KXP-PPN1527153185 |e 2901842690 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.03.2016"],"language":["eng"],"recId":"1527153185","person":[{"family":"Aichler","given":"Michaela","roleDisplay":"VerfasserIn","display":"Aichler, Michaela","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Ott, Katja","role":"aut","family":"Ott","given":"Katja"}],"title":[{"title":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy","title_sort":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy"}],"physDesc":[{"extent":"13 S."}],"relHost":[{"id":{"eki":["63035975X"],"zdb":["2560162-3"],"issn":["1949-2553"]},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar]","publisher":"Impact Journals LLC","dateIssuedKey":"2010","dateIssuedDisp":"2010-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"OncoTarget","subtitle":"open access impact journal","title":"OncoTarget"}],"recId":"63035975X","language":["eng"],"note":["Gesehen am 16.08.2018"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapyOncoTarget","part":{"text":"5(2014), 16, Seite 6620-6632","volume":"5","extent":"13","year":"2014","pages":"6620-6632","issue":"16"},"pubHistory":["1.2010,Mai -"]}],"name":{"displayForm":["Michaela Aichler, Martin Motschmann, Uta Jütting, Birgit Luber, Karen Becker, Katja Ott, Florian Lordick, Rupert Langer, Marcus Feith, Jörg Rüdiger Siewert and Axel Walch"]},"origin":[{"dateIssuedDisp":"August 2014","dateIssuedKey":"2014"}],"id":{"doi":["10.18632/oncotarget.2268"],"eki":["1527153185"]}} | ||
| SRT | |a AICHLERMICEPIDERMALG2014 | ||